Afpedia > Products >Chemicals >Biochemical Industry >Finished Medicine> Pharmaceutical Grade Oxytocin Medicine Injection For Induced Labor

Supplier Details

  • Anhui BBCA Pharmaceutical Co.,Ltd.

  • This supplier is an uncertified member of Afrindex. To ensure your interest, Afrindex will first verify this supplier information before publishing his contacts.
  • Location: ******
  • Tel: ******
  • Mobile: ******
  • Email: ******

Service For Buyers

Hot Products

Sponsor Advertsing

Pharmaceutical Grade Oxytocin Medicine Injection For Induced Labor

  • FOB Price : US $0.3-0.5
  • MOQ: 500000 AmpoulesPieces
  • Port : shanghai
  • Payment Terms : Western Union,T/T,L/C
  • Production Capacity: 1000000 Ampoules per day


Add to My Basket You can manage your basket in member center

  • Basic Info
  • Company Profile
  • Packaging Details:carton
  • Origin:China
  • Model Number:BBCA18022616
  • Brand Name:BBCA

Product Description

  • Pharmaceutical Grade Oxytocin Medicine Injection For Induced Labor


    1. Product Name:  Gynecology Medicine Pharmaceutical Grade Oxytocin Injection
    2. Component:  Main ingredients: ofloxacin.
    3. Appearance: This product is colorless transparent or almost transparent liquid.
    4. Indications:  Used for induced labor, oxytocin, postpartum and miscarriage caused by contractions are weak or shrink after bad uterine bleeding;Understand the placental function (oxytocin irritability test).
    5. Specifications: 1ml: 10U/5U
    6. Usage and Dosage:  
     (1) induced labor or oxytocin intravenous drip, a 2.5 ~ 5 units, with sodium chloride injection diluted to each 1 ml contains 0.01 units.Static drop at the beginning of not more than 0.001 ~ 0.002 units per minute, 0.001 ~ 0.002 units per 15 ~ 30 minutes, to achieve contractions are similar to normal during delivery, no more than 0.02 units per minute, fastest is generally 0.002 ~ 0.005 units per minute.
    (2) control postpartum hemorrhage static drop of 0.02 ~ 0.04 units per minute, the placenta after discharge units and intramuscular injection of 5 ~ 10.
    7. Contraindications:  Pelvic too narrow, the birth canal, obvious abnormal head basin don't say and position, has a history of cesarean section, the uterus myoma eliminating art history and umbilical cord presentation or prolapse, placenta previa, fetal distress, contractions are too strong, weakness of uterine contraction long-term medication is invalid, antepartum haemorrhage (including placental abruption), multiple pregnancy, the uterus is too large (include hydramnios), severe pregnancy-induced hypertension syndrome.
    8. Pharmacological mechanisms:  Oral easily damaged by digestive juices, the oral invalid;Intranasal by mucous membrane is quickly absorbed, aged about 20 minutes;Intramuscular injection in 3 ~ 5 minutes work, role for 30 ~ 60 minutes;Intravenous drip effect immediately, 15 ~ 60 minutes uterine contraction frequency and strength increase gradually, then stable, drip after 20 minutes, the effect gradually decreases.General T1/2 to 1-6 minutes.This product by the metabolism of liver, kidney, the renal excretion, very little is prototype.
    9. Storage: Protect from light, airtight preservation,stored within temperature of 20℃.
    10. Package: 10 Ampoules/Box; 100 Boxes/Carton

Photo Show

  •  BBCA PHARMA, a subsidiary of BBCA Group, is the first pharmaceutical listed company in Anhui province (It was listed in Shenzhen Stock Exchange in 2000 and the Stock Code is 000153). Established for almost 60 years, BBCA PHARMA has successively earned a reputation of China’s Top 100 Pharmaceutical Industries for several years since 2006.

        Integrating R&D, manufacturing with sales, BBCA PHARMA has developed into a national high and new tech enterprise, leading with large-volume transfusion (the annual amount is over 500 million bottles/bags) and assisting by analgesic-antipyretic, cardiovascular, antibiotic products, etc. 53 international production lines certified by GMP, its products include more than ten kinds of dosage forms and 300 varieties of drugs, involving fields of bio-pharmaceutical, chemical pharmaceutical, Chinese Herbal Medicine and APIs.

        Employing more than 5,000 staff, the sales income of BBCA PHARMA has been over 3 billion. BBCA PHARMA owns seven pharmaceutical factories, one National Pharmaceutical R&D Center, six pharmaceutical marketing companies and one pharmacy chain with more than 600 pharmacies. In which, the international business company mainly engage in exporting business of APIs and preparations, importing raw materials, equipment procurement and registration of drugs. Varieties of preparations have been registered and marketed in Myanmar, Vietnam, the Philippines, Uzbekistan, Pakistan, Nigeria, Ecuador, Cameroon and many other countries.

       The APIs and preparations of BBCA PHARMA have been exported not only to developing countries and regions such as Asia, Africa and Latin America, but also to developed markets such as Europe, America, Japan and Korea.

      BBCA can provide technical services for your enterprise by utilizing the mature production technologies of various drugs, and provide the OEM servise as well.

  • More >

Basic Information

  • Chemicals-Biochemical Industry-Active Pharmaceutical Ingredient
  • BBCA
  • 1997-08-30
  • manufacturing enterprise
  • Main APIs“”Aspirin-DL-Lysine,Paracetamol,Sodium Lactate,Cefuroxime Axetil,D-Fructose,Propacetamol Hydrochloride and so on. Main Pharmaceutical Preparations:Propacetamol Tablets/Capsules,Sodium Chloride Injection,Oxytocin Injection,Metronidazole Injection,Levofloxacin Hydrochloride Capsules,Ceftriaxone Sodium for injection and so on.
  • Myanmar, Vietnam, the Philippines, Uzbekistan, Pakistan, Nigeria, Ecuador, Cameroon and many other countries.
  • >60%
  •  YES
Enter between 20 to 4,000 characters